Research
Current research activities
- CONTRACT RESEARCH
Study title: Multicenter, open-label, single dose study to evaluate safety, tolerability and pharmacokinetics of LCZ696 followed by a 52-week randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared with enalapril in pediatric patients from 1 month to < 18 years of age with heart failure due to systemic left ventricle systolic dysfunction. - Dr MAMMEN
i) Impact of COVID-19 Pandemic on Paediatric Cardiology services
at Chris Hani Baragwanath Academic Hospital
ii) “Prevalence of Congenital Heart Disease in a large tertiary
hospital in South Africa over a 20-year period”